Company Filing History:
2 out of 2 
1 out of 5 
1 out of 3 Years Active: 2011-2017
Title: Francesco Tedesco: Innovator in Antibody Therapeutics
Introduction
Francesco Tedesco is a prominent inventor based in Trieste, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 5 patents, Tedesco's work focuses on innovative solutions for medical challenges.
Latest Patents
Among his latest patents, Tedesco has developed antibodies targeting β2-glycoprotein I, which are crucial for treating conditions such as antiphospholipid syndrome (APS). This invention includes human recombinant antibodies or fragments that can prevent thrombus formation and fetal loss. Another notable patent involves anti-C5 alpha antibodies, which are designed to inhibit the complement system's activation, thereby addressing diseases related to tissue damage.
Career Highlights
Throughout his career, Tedesco has worked with various companies, including Adienne Srl and Adienne S.a. His expertise in antibody development has positioned him as a key player in the biotechnology sector. His innovative approaches have led to advancements in therapeutic applications, enhancing patient care.
Collaborations
Tedesco has collaborated with notable professionals in his field, including Roberto Marzari and Daniele Sblattero. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Francesco Tedesco's contributions to antibody therapeutics exemplify the impact of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.